.png){kind=logo}
Adults
Adult-diagnosis of autism has increased significantly over the past 20 years. Receiving an autism diagnosis as an adult can bring a sense of relief and offer a better understanding of oneself. It can also be a confusing and challenging time. However, many people find that there is a paucity of support for autistic adults.
​
Our adult team have been providing free and effective group programs to autistic adults for the past 10 years. These include cognitive-behaviour therapy (CBT) groups for autistic adults seeking support to manage social skills and anxiety, and for neurotypical adults struggling with social anxiety. We’ve also partnered with industry to develop a supported workplace program for autistic adults and to trial an AI-assisted technology that supports adults with intellectual disabilities.
​
Our programs are evidence-based and include gold-standard therapies. We have supported more than 700 adults through these programs in the last decade, while gaining a deeper understanding of how the brain and body is influenced by psychological and practical support.
Current research
CBT group therapy programs for social anxiety or autism
We run two group-based gold-standard CBT programs: one for autistic adolescents and adults seeking support to manage social skills and anxiety, and one for neurotypical adults living with social anxiety disorder (SAD). Both programs are free.
This trial is currently recruiting.
Adults aged 18-65 experiencing difficulties with alcohol
​Building on our innovative oxytocin research, we are seeking participants who experience difficulties with alcohol to participate in a research study investigating the effectiveness of a new nasal spray to help reduce alcohol use and craving.
This trial is currently recruiting.
Improving work outcomes for autistic adults with a supported workplace program
Achieving, maintaining, and thriving in employment can be difficult for many autistic adults. We’ve partnered with workplaces to improve accessibility, training and processes that deliver increased work opportunities for autistic adults.
Investigate the efficacy, safety, and tolerability of ML-004 in autistic adolescents and adults
In the IRIS study, we are looking to find out
whether the investigational study drug,
designated ML-004, will help alleviate some of
the challenges that can impact communication
in those on the autism spectrum.
This trial is currently recruiting.